Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 10/20 | 0.59 |
| ▸ | DDB1 | Q16531 | 6/20 | 0.59 |
| ▸ | STAT3 | P40763 | 1/20 | 0.42 |
| ▸ | BRD9 | Q9H8M2 | 2/20 | 0.42 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.41 |
| ▸ | GSPT1 | P15170 | 1/20 | 0.41 |
| ▸ | IRAK4 | Q9NWZ3 | 4/20 | 0.41 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.40 |
| ▸ | BTK | Q06187 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30893196 | 0.94 | CRBN (0.55) | CRBNDDB1STAT3BRD9LRRK2 | |
| SCHEMBL23705538 | 0.88 | CRBN (0.57) | CRBNDDB1LRRK2IRAK4BTK | |
| SCHEMBL30058679 | 0.88 | CRBN (0.57) | CRBNDDB1LRRK2IRAK4BTK | |
| SCHEMBL29617100 | 0.86 | CRBN (0.59) | CRBNDDB1LRRK2IRAK4AR | |
| SCHEMBL23729950 | 0.86 | CRBN (0.59) | CRBNDDB1LRRK2IRAK4AR | |
| SCHEMBL29617105 | 0.86 | CRBN (0.59) | CRBNDDB1LRRK2IRAK4AR | |
| SCHEMBL30378605 | 0.85 | CRBN (0.71) | CRBNDDB1STAT3 | |
| SCHEMBL23317936 | 0.85 | CRBN (0.71) | CRBNDDB1STAT3 | |
| SCHEMBL30893300 | 0.85 | CRBN (0.53) | CRBNDDB1BRD9GSPT1 | |
| SCHEMBL23729668 | 0.83 | CRBN (0.75) | CRBNDDB1STAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024097948-A1 | DEGRADERS OF MDM2 AND USES THEREOF | ROIVANT DISCOVERY, INC. (US) | 2024-05-10 | — | — | WO | disclosed |